Thema
Letter
Comment
19.251
Case Reports
2.824
Antibodies, Monoclonal
427
Anti-Bacterial Agents
426
Comparative Study
404
Antibodies, Monoclonal, Humanized
378
Antineoplastic Agents
376
Anticoagulants
351
Research Support, Non-U.S. Gov't
340
Aspirin
261
R16CO5Y76E
261
Klinische Studie
251
Hypoglycemic Agents
241
Antiviral Agents
224
Platelet Aggregation Inhibitors
222
Antibodies, Viral
212
EC 2.7.10.1
200
Recombinant Proteins
199
Glucocorticoids
193
Historical Article
189
Immunosuppressive Agents
177
Insulin
167
Antihypertensive Agents
160
5Q7ZVV76EI
151
Warfarin
151
9005-49-6
150
Heparin
150
Pyrimidines
150
Blood Glucose
143
Hydroxymethylglutaryl-CoA Reductase Inhibitors
142
Angiotensin-Converting Enzyme Inhibitors
139
Autoantibodies
134
Fibrinolytic Agents
134
Biomarkers
133
COVID-19 Vaccines
129
Research Support, N.I.H., Extramural
125
Piperazines
121
Immunoglobulin G
115
Prednisone
115
VB0R961HZT
115
Adrenergic beta-Antagonists
114
Anti-Inflammatory Agents, Non-Steroidal
110
Pyrazoles
109
Antitubercular Agents
104
Oxygen
104
S88TT14065
104
EC 3.4.21.68
102
Tissue Plasminogen Activator
102
Bronchodilator Agents
96
mehr ...